M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
EpiCept Corporation files for EU marketing approval of Ceplene
EpiCept Corporation (Nasdaq and OMX Stockholm: EPCT), an emerging speciality pharmaceutical company, said on 9 October that it has applied for marketing approval of Ceplene (histamine dihydrochloride), its lead oncology product candidate, in the European Union.
The company has submitted a...
If you want to view the full text of this story, you must first purchase archive retrieval credits.